Advances in biomarkers and techniques for pancreatic cancer diagnosis.

Wu, Haotian; Ou, Suwen; Zhang, Hongli; Huang, Rui; Yu, Shan; Zhao, Ming; Tai, Sheng

Wu, Haotian; Ou, Suwen; Zhang, Hongli; Huang, Rui; Yu, Shan; Zhao, Ming; Tai, Sheng.

Afiliação

Wu H; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Ou S; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Zhang H; Harbin Medical University, Harbin, 150086, China.
Huang R; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Yu S; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. yushan@hrbmu.edu.cn.
Zhao M; Department of Gastroenterology, The First Affiliated Hospital of Chengdu Medical College, Sichuan, 610500, China. zhaoming24@126.com.
Tai S; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. taisheng1973@163.com.

Cancer Cell Int ; 22(1): 220, 2022 Jun 28.

Article em En | MEDLINE | ID: mdl-35761336

Palavras-chave

Artificial intelligence; Biomarkers; Diagnosis; Nanomaterials; Pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google